Middle East and Africa Precision Medicine Market – Size, Outlook, Trends and Forecast (2024 – 2032)

Precision medicine is an emerging medical approach that helps in the treatment by providing customised medicine based on their medical decisions, practices, and allows doctors and physicians to study the individual response to a medication. This medicine will allow researchers and doctors to estimate accurately to prevent various diseases. Initially, precision medicine is focused on oncology, like cancer, it is one of the significant causes of death globally with an increase in ageing population.

The Middle East & Africa Precision Medicine Market Segments Size & Growth:

The Middle East & AfricaPrecision MedicineMarket is accounted for $XXbillion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth owing to the adoption of gene therapy, number of chronic diseases, and improvements in big data analytics. However, high cost for customised medicine and misinterpretation of genetic data hinder the growth of the Middle East and Africa precision medicine market.

The Middle East & Africa Precision Medicine Market Segments Share:

The Middle East & Africaprecision medicine market is categorised into by type of technology which consists of bioinformatics, gene sequencing, big data analytics, drug discovery, and companion diagnosis. Drug discovery has the most significant share due to the increase of chronic diseases such as cancer, diabetes, and so on. By application, precision medicine market is segmented as immunology, neurology, respiratory, and CNS. Among all oncology are expected to have high growth rate during the forecast period 2018-2024, because of increase in cancer cases.

By Geography, South Africa is dominating the Precision Medicine market, and the growth in the Middle East & Africa is mainly attributed because of the increasing demand for personalised medicine and rise in diseases. Furthermore, the MiddleEast is witnessing the fastest growth during the forecast period, due to rising ageing population, chronic conditions and investment in R&D research.

The Middle East & AfricaPrecision Medicine MarketSegmentsTrends:

• In January 2018, treatment for breast cancer through personalised medicine has been discovered by the University of Alberta researchers which can form cancer cell susceptible to the treatment.
• In March 2017, Silicon Biosystems Inc. has wholly acquired CellSearch Assets its first entry into the diagnosis market.
• In July 2017, Cardinal Health has wholly acquired Medtronic’s Patient Care business to enhance the production of present medical products.

The Middle East & AfricaPrecision Medicine Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and the global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

• Teva Pharmaceutical
• Nanostring Technologies
• Tepnel Pharma Services
• QIAGEN
• Laboratory Corporation of America Holdings